About the Authors

Thomas B. Campbell
Division of Infectious Diseases, Department of Medicine, University of Colorado School of Medicine, Aurora, United States of America

Laura M. Smeaton, Yun Chen, Victor De Gruttola
Center for Biostatistics in AIDS Research, Harvard School of Public Health, Boston, Massachusetts, United States of America

N. Kumarasamy
YRG Centre for AIDS Research & Education, Chennai, India

Timothy Flanigan
Brown Medical School, Providence, Rhode Island, United States of America

Karin L. Klingman, Ana I. Martinez
National Institutes of Health, Bethesda, Maryland, United States of America

Cynthia Firnhaber
Clinical HIV Research Unit, Department of Medicine, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa

Beatriz Grinsztejn
Evandro Chagas Clinical Research Institute, Fiocruz, Rio de Janeiro, Brazil

Mina C. Hosseinipour
Kamuzu Central Hospital, Lilongwe, Malawi

Johnstone Kumwenda
Department of Medicine, College of Medicine, Blantyre, Malawi

Umesh Lalloo
Nelson R. Mandela School of Medicine, Durban, South Africa

Cynthia Riviere
Institut Nacional de laboratoire et de Recherches, Port-au-Prince, Haiti

Jorge Sanchez
Asociación Civil Impacta Salud y Educación, Lima, Peru

Marineide Melo
Servico de Infectology, Hospital Nossa Senhora da Conceicao-GHC, Porto Alegre, Brazil

Khuanchai Supparatpinyo
Department of Medicine and Research Institute for Health Sciences, Chiang Mai University, Chiang Mai, Thailand

Srikanth Tripathy
National AIDS Research Institute, Pune, India

Apsara Nair, Ann Walawander
Frontier Science & Technology Research Foundation, Amherst, Massachusetts, United States of America

Laura Moran
Social & Scientific Systems, Inc, Silver Spring, Maryland, United States of America

Wendy Snowden
GlaxoSmithKline, Research Triangle Park, North Carolina, United States of America

James F. Rooney
Gilead Sciences, Inc., Foster City, California, United States of America

Jonathan Uy
Bristol-Myers Squibb Company, Plainsboro, New Jersey, United States of America

Robert T. Schooley
University of California San Diego, San Diego, United States of America

James Gita Hakim
University of Zimbabwe College of Health Sciences, Harare, Zimbabwe

Corresponding Author

thomas.campbell@ucdenver.edu

Competing Interests

TBC has received payments for lectures from, and served as a consultant for GlaxoSmithKline. TF has stock ownership in Abbot, Bristol-Myers Squibb, Gilead Sciences, GlaxoSmithKline and has served as a consultant for Gilead Sciences. WS is an employee of GlaxoSmithKline. JFR is an employee and stockholder of Gilead Sciences. JU is an employee of Bristol-Myers Squibb. RTS has served as a consultant to GlaxoSmithKline, Gilead Sciences, Merck and Bristol-Myers Squibb. RTS has served as a member of Data and Safety Monitoring Boards for Gilead Sciences and had research contracts with Merck and Bristol-Myers Squibb. LMS, KLK, CF, BG, MCH, JK, UL, CR, JS, MM, KS, ST, AIM, AN, AW, LM, YC, VDG and JGH declare no conflicts of interest.

Author Contributions

Conceived and designed the experiments: TBC LMS NK TF KLK BG MCH JK UL KS ST AIM AN AW RTS VDG JGH. Performed the experiments: TBC NK TF KLK CF BG MCH JK UL CR JS MM KS ST AIM AN AW LM RTS JGH. Analyzed the data: LMS VDG YC. Contributed reagents/materials/analysis tools: WS JFR JU. Wrote the first draft of the manuscript: TBC. Contributed to the writing of the manuscript: TBC LMS NK TF KLK CF BG MCH JK UL CR JS MM KS ST AIM LM YC WS JFR JU RTS VDG JGH. ICMJE criteria for authorship read and met: TBC LMS NK TF KLK CF BG MCH JK UL CR JS MM KS ST AIM AN AW LM YC WS JFR JU RTS VDG JGH. Agree with manuscript results and conclusions: TBC LMS NK TF KLK CF BG MCH JK UL CR JS MM KS ST AIM AN AW LM YC WS JFR JU RTS VDG JGH. Enrolled patients: TBC NK TF CF BG MCH JK UL CR JS MM KS ST RTS JGH.